Tobias Financial Advisors, Inc. Mesoblast LTD Transaction History

Tobias Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.73 - $3.7 $54,600 - $74,000	20,000 New	20,000 $58,000
Q1 2022 May 09, 2022	BUY	$3.58 - $4.98 $71,600 - $99,600	20,000 New	20,000 $84,000
Q4 2021 Feb 09, 2022	SELL	$4.17 - $7.09 $83,400 - $141,800	-20,000 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$11.33 - $19.81 $67,980 - $118,859	-6,000 Reduced 23.08%	20,000 $372,000
Q4 2019 Feb 04, 2020	BUY	$5.74 - $7.42 $149,240 - $192,920	26,000 New	26,000 $191,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Tobias Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tobias Financial Advisors, Inc. with notifications on news.